Dr. Carmen Renee Bergom, MD

Dr. Bergom practices at BJC Northwest Healthcare in Florissant, Missouri.

Dr. Bergom's NPI, 1932363553, was assigned on July 13, 2008. Dr. Bergom graduated from Medical College of Wisconsin in 2008. Dr. Bergom holds Missouri license 2020031317.

Dr. Bergom's primary practice is BJC Northwest Healthcare, at 1225 Graham Rd, Florissant, MO 63031 in Saint Louis County. The practice phone is (314) 653-5000.

Dr. Bergom's primary practice is BJC Northwest Healthcare in Florissant, Missouri. Dr. Bergom is also affiliated with Barnes-Jewish Hospital. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Bergom to 3 more hospitals, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bergom practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Bergom's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Bergom is licensed in Missouri.

CMS data shows 142 Medicare services from Dr. Bergom across 3 procedure codes in 2024, for 30 Medicare patients. Medicare paid $8,683 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 30 Medicare patients who saw Dr. Bergom in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bergom's median patient age at 72, with 76% women.

In 2024, Dr. Bergom wrote 32 Medicare Part D claims for 20 patients. 100% of them were for generic drugs. CMS names the drug for 26 of them, across 1 drug with 11 or more claims each, at $438 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Bergom for performance year 2024, reported as part of a group. Dr. Bergom accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 86 papers to Dr. Bergom, published from 2011 to 2025. 2023 was the busiest year, with 15. The most frequent topics are Breast Neoplasms, Heart and Cardiotoxicity. Dr. Bergom has published most often in Int J Radiat Oncol Biol Phys. Dr. Bergom's most frequent co-authors are Adam D. Currey, MD, Amanda L. Kong, MD and Chandler Scott Cortina, MD.

Dmand AI links Dr. Bergom to 8 clinical trials, 2 of them phase 3 studies. 5 are still active or recruiting. Conditions studied include Breast Carcinoma In Situ, Breast Neoplasms and Carcinoma, Intraductal, Noninfiltrating. Washington University School of Medicine sponsors the most, 3.

CMS Open Payments shows 6 general payments to Dr. Bergom from 5 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Elekta, Inc. paid the most, $195.

Dr. Bergom graduated from Medical College of Wisconsin in 2008.